Physician profile
James E Ferguson
NPI 1467689919
$4,401.22
in general payments reported to CMS, 2019-2025
13 companies · $399 in 2025
The $399 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,130 · 2021: $19.57 · 2022: $155 · 2023: $387 · 2024: $311 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,050 · Education: $47.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,049.59 |
| Education | $47.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $3,165.06 | 2019-2025 | Imfinzi |
| Boston Scientific Corporation | $381.70 | 2022-2025 | Lithovue |
| Ferring Pharmaceuticals INC. | $157.49 | 2024 | Adstiladrin |
| Coloplast Corp | $145.34 | 2025 | |
| Urogen Pharma, INC. | $143.84 | 2022-2024 | |
| Seagen INC. | $93.50 | 2023 | Padcev |
| Karl Storz Endoscopy-America | $87.17 | 2023 | Flex-X / Image 1 S |
| Janssen Scientific Affairs, LLC | $78.98 | 2023 | Erleada |
| Novo Nordisk INC | $74.11 | 2025 | Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.63 | 2024 | Xifaxan |
| Photocure INC | $19.57 | 2021 | |
| Medtronic, INC. | $17.90 | 2025 | Venaseal |
| Glaxosmithkline, LLC. | $14.93 | 2025 | Trelegy Ellipta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ferguson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.